Department of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City.
Department of Otolaryngology, Nebraska Methodist Health System, Omaha.
JAMA Otolaryngol Head Neck Surg. 2022 Oct 1;148(10):947-955. doi: 10.1001/jamaoto.2022.2312.
In clinically localized (T1-2) oral cavity squamous cell carcinoma (OCSCC), regional lymph node metastasis is associated with a poor prognosis. Given the high propensity of subclinical nodal disease in these patients, upfront elective neck dissections (END) for patients with clinically node-negative disease are common and associated with better outcomes. Unfortunately, even with this risk-adverse treatment paradigm, disease recurrence still occurs, and our understanding of the factors that modulate this risk and alter survival have yet to be fully elucidated.
To investigate the prognostic value of lymph node yield (LNY), lymph node ratio (LNR), and weighted LNR (wLNR) in patients with clinically node-negative T1-2 OCSCC.
DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, data were collected retrospectively from 7 tertiary care academic medical centers. Overall, 523 patients with cT1-2N0 OCSCC who underwent elective neck dissections after primary surgical extirpation were identified.
Lymph node yield was defined as the number of lymph nodes recovered from elective neck dissection. Lymph node ratio was defined as the ratio of positive nodes against total LNY. Weighted LNR incorporated information from both LNY and LNR into a single continuous metric.
Locoregional control (LRC) and disease-free survival (DFS) were both evaluated using nonparametric Kaplan-Meier estimators and semiparametric Cox regression.
On multivariable analysis, LNY less than or equal to 18 lymph nodes was found to be significantly associated with decreased LRC (aHR, 1.53; 95% CI, 1.04-2.24) and DFS (aHR, 1.46; 95% CI, 1.12-1.92) in patients with pN0 disease, but not those with pN-positive disease. Importantly, patients with pN0 disease with LNY less than or equal to 18 and those with pN1 diseasehad nearly identical 5-year LRC (69.7% vs 71.4%) and DFS (58.2% vs 55.7%). For patients with pN-positive disease, LNR greater than 0.06 was significantly associated with decreased LRC (aHR, 2.66; 95% CI, 1.28-5.55) and DFS (aHR, 1.65; 95% CI, 1.07-2.53). Overall, wLNR was a robust prognostic variable across all patients with cN0 disease, regardless of pathologic nodal status. Risk stratification via wLNR thresholds demonstrated greater optimism-corrected concordance compared with American Joint Committee on Cancer (AJCC) 8th edition nodal staging for both LRC (0.61 vs 0.57) and DFS (0.61 vs 0.58).
Movement toward more robust metrics that incorporate quantitative measures of neck dissection quality and regional disease burden, such as wLNR, could greatly augment prognostication in cT1-2N0 OCSCC by providing more reliable and accurate risk estimations.
在临床局限性(T1-2)口腔鳞状细胞癌(OCSCC)中,区域淋巴结转移与预后不良相关。鉴于这些患者亚临床淋巴结疾病的高倾向,对于临床淋巴结阴性疾病的患者进行预防性选择性颈部清扫术(END)是常见的,并且与更好的结果相关。不幸的是,即使采用这种风险规避的治疗方案,疾病仍会复发,我们对调节这种风险和改变生存的因素的理解尚未完全阐明。
研究临床淋巴结阴性 T1-2 OCSCC 患者的淋巴结产量(LNY)、淋巴结比(LNR)和加权 LNR(wLNR)的预后价值。
设计、设置和参与者:在这项队列研究中,数据从 7 个三级护理学术医疗中心进行回顾性收集。总共确定了 523 名接受原发性手术切除后接受选择性颈部清扫术的 cT1-2N0 OCSCC 患者。
淋巴结产量定义为从选择性颈部清扫术获得的淋巴结数量。淋巴结比定义为阳性淋巴结与总 LNY 的比值。加权 LNR 将来自 LNY 和 LNR 的信息合并到一个单一的连续指标中。
局部区域控制(LRC)和无病生存(DFS)均使用非参数 Kaplan-Meier 估计和半参数 Cox 回归进行评估。
多变量分析发现,LNY 小于或等于 18 个淋巴结与 pN0 疾病患者的 LRC 降低显著相关(aHR,1.53;95%CI,1.04-2.24)和 DFS(aHR,1.46;95%CI,1.12-1.92),但与 pN 阳性疾病患者无关。重要的是,LNY 小于或等于 18 的 pN0 疾病患者和 pN1 疾病患者的 5 年 LRC(69.7%对 71.4%)和 DFS(58.2%对 55.7%)几乎相同。对于 pN 阳性疾病患者,LNR 大于 0.06 与 LRC 降低显著相关(aHR,2.66;95%CI,1.28-5.55)和 DFS(aHR,1.65;95%CI,1.07-2.53)。总体而言,wLNR 是所有 cN0 疾病患者的可靠预后变量,无论病理淋巴结状态如何。通过 wLNR 阈值进行风险分层,与第 8 版 AJCC 淋巴结分期相比,LRC(0.61 对 0.57)和 DFS(0.61 对 0.58)的校正一致性更好。
向更稳健的指标发展,这些指标结合了颈部清扫质量和区域疾病负担的定量测量,例如 wLNR,可能通过提供更可靠和准确的风险估计,极大地提高 cT1-2N0 OCSCC 的预后。